FDA Declines to Approve Mylan ' s Generic Of GSK ' s Advair for Now FDA Declines to Approve Mylan ' s Generic Of GSK ' s Advair for Now

Mylan NV said on Wednesday the U.S. Food and Drug Administration declined to approve its generic version of GlaxoSmithKline Plc ' s blockbuster Advair asthma treatment, but provided no details of the agency ' s concerns or how long the product might be delayed.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news